Clinical Report: The Impact of Financial Toxicity on ASCT Preparation
Overview
This study explores the indirect expressions of financial toxicity faced by patients preparing for autologous stem cell transplant (ASCT) for multiple myeloma. Findings indicate that financial strain significantly influences treatment readiness and decision-making, highlighting the necessity for proactive financial navigation.
Background
Financial toxicity is a critical issue in cancer care, particularly affecting patients with hematologic malignancies like multiple myeloma. The burden of treatment costs can lead to adverse psychosocial outcomes and decreased quality of life. Understanding how financial toxicity manifests during ASCT preparation is essential for improving patient support and care.
Data Highlights
No numerical data presented in the article.
Key Findings
Financial toxicity often emerges indirectly through work disruption and caregiver burdens.
Patients frequently minimize discussions about financial concerns, prioritizing medical necessity over costs.
Nearly half of patients undergoing ASCT experience meaningful financial hardship.
Financial strain is linked to worse health-related quality of life and mental health outcomes.
Clinical Implications
Healthcare providers should recognize the relational and logistical challenges posed by financial toxicity in ASCT preparation. Proactive financial navigation strategies are essential to support patients and their families in managing these burdens effectively.
Conclusion
Highlight the importance of qualitative research in understanding financial toxicity.